|
Symbol
|
P322TQ | VOWLTQ | WEVLTQ | WXNLTQ | LVBVLK | EOJRCH | RMABXV | YOTLTQ | RMBWDV | RMAVSV | RMAXKV | BTJBKB | ZPRLTQ | OCGRCH | LTHCLK | AAHUTQ | ONFRCH | RMBE8V | OOJRCH | AAIETQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | LUKB Autocallable Multi Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti | Multi Vonti | Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Worst of Reverse Convertible |
|
Sous-jacent
|
Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Apple Inc. / Coca-Cola Co. / LVMH Moet Hennessy Louis Vuitton / Nestlé S.A. / UNILEVER TMICC BASKET | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé S.A. / Swatch Group I / Swiss Life Hldg. N / Swiss RE AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS / UBS / Zurich | Holcim/Amrize Basket / Kühne & Nagel Intl. AG / Nestlé S.A. / Novartis AG / Roche AG | Holcim/Amrize Basket / Nestlé S.A. / Novartis AG / Swiss RE AG / Zurich Insurance Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Nestlé / Novartis / Roche GS / UBS / Zurich | ABB N / Nestlé N / Novartis N / Roche GS / Swiss RE AG | Danone S.A. / Kraft Heinz Co. / Nestlé N | Barry Callebaut AG / Nestlé S.A. / SGS S.A. Ltd. | Nestlé / Novartis | Barry Callebaut AG / Nestlé S.A. / Roche AG / Swiss RE AG / UBS Group AG | Nestlé / Novartis / Roche GS |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
23.12.2025 | 23.12.2027 | 31.03.2028 | 30.06.2028 | 20.07.2026 | 14.01.2026 | 12.10.2026 | 24.11.2027 | 27.07.2026 | 23.02.2026 | 23.12.2025 | 08.04.2027 | 23.04.2027 | 26.04.2027 | 09.07.2027 | 22.07.2026 | 08.04.2026 | 13.07.2026 | 15.07.2026 | 19.07.2027 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
66,90 | 30,865 | 71,27 | 58,95 | 172,51 | 287,84 | 182,96 | 178,20 | 63,33 | 47,42 | 79,63 | 68,75 | 63,975 | 58,5776 | 61,3248 | 64,764 | 1 098,00 | 83,70 | 997,10 | 140,14 |
| rendement max. p.a. | 133,86% | 9,44% | 5,10% | 6,34% | 19,78% | -5,18% | 9,72% | 6,02% | 4,59% | 79,19% | - | 3,65% | 3,06% | 4,19% | 5,43% | - | 13,96% | 21,25% | 9,53% | 1,42% |
| Demande | - | - | 100,69 | 94,91 | - | 100,78 | 95,90 | 96,22 | 100,00 | 79,00 | - | 100,41 | 103,42 | - | - | 97,10 | - | 91,90 | 97,90 | - |
| Offre | - | - | 101,50 | 95,71 | - | 101,59 | 96,70 | 97,02 | 101,00 | 86,00 | - | 101,22 | 104,25 | - | - | - | - | 93,20 | 98,70 | - |